Hither neurology: research.
Author:
Open Access
- 1 March 1992
- journal article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 55 (Suppl) , 26-31
Abstract
Neurological disability may be prevented, or it may be alleviated if prevention is impossible or ineffective. Research into prevention and alleviation can be "laboratory" or "clinical", the latter being no less scientific than the former. All proposed treatments must be properly evaluated to ensure that effective interventions are widely adopted and ineffective ones abandoned. Unless an intervention has a major effect on outcome (which most do not), the most efficient assessment is by random allocation of patients to the new intervention versus the old. Although there were, and still are, forces opposed to the proper evaluation of treatment, there are strong economic clinical arguments in its favour, which will lead to appropriate targeting of scarce health resources.Keywords
This publication has 8 references indexed in Scilit:
- Are Clinical Trials a Cost-effective Investment?JAMA, 1989
- Are clinical trials a cost-effective investment?1989
- All change for research.BMJ, 1987
- Hyperbaric oxygen and multiple sclerosis: final results of a placebo-controlled, double-blind trial.Journal of Neurology, Neurosurgery & Psychiatry, 1987
- Antifibrinolytic agents in subarachnoid haemorrhageJournal of Neurology, 1987
- Controlled Trials of Electroconvulsive TherapyAnnals of the New York Academy of Sciences, 1986
- Referrals to neurologists for headaches not due to structural disease.Journal of Neurology, Neurosurgery & Psychiatry, 1981
- The effect of a visit to a neurological clinic upon patients with tension headache.1980